跳至主要内容
临床试验/NCT00570856
NCT00570856终止4 期

Clinical Trial of Effectiveness of Folic Acid Therapy on Homocysteine Level and Carotid Intima-Media Thickness After Kidney Transplantation

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 60 人开始时间: 2005年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
60
主要终点
plasma level of total homocysteine (tHcy)

研究概览

简要总结

To see the effect of Folic acid supplementation after kidney transplantation on plasma total homocysteine level and carotid intimal-media thickness

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
25 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • having hyperhomocysteinemia(tHcy>12.5 µmol/L in men and 11.5 µmol/L in women )
  • No evident history of CVD
  • no evidence of cigarette smoking
  • not participating in other clinical studies on evaluation of cardiac diseases and
  • not taking any lipid lowering treatment
  • not being pregnant or breast feeding a baby(women)
  • Having HIV or viral hepatitis infections.

排除标准

  • unstable condition of the transplanted kidney (Cr> 3 mg/dl, BUN > 50 mg/dl)
  • Cyclosporine (CsA) intoxication
  • New onset of any severe disease ( such as MI, stroke, DM, etc.).

研究组 & 干预措施

1

Experimental

Folic acid supplementation

干预措施: Folic acid (Drug)

2

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

plasma level of total homocysteine (tHcy)

时间窗: 6 months

次要结局

  • carotid intima-media thickness (cIMT)(6 months)

研究者

相似试验